Skip to Content

UriFlex

This page contains information on UriFlex for veterinary use.
The information provided typically includes the following:
  • UriFlex Indications
  • Warnings and cautions for UriFlex
  • Direction and dosage information for UriFlex

UriFlex

This treatment applies to the following species:
Manufacturer: Butler Schein™ Animal Health

Premium Therapy

Phenylpropanolamine Hydrochloride

50 mg Chewable Tablets

FOR USE IN DOGS ONLY

UriFlex Caution:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description:

UriFlex-PT chewable tablets contain 50 mg of phenylpropanolamine hydrochloride. Phenylpropanolamine is an α-adrenergic agonist which has been shown to increase urethral sphincter pressure in dogs. Loss of urethral sphincter tone and decreased sphincter pressure is associated with urinary incontinence in ovariohysterectomized or anestrous dogs.

UriFlex Indications:

UriFlex-PT is indicated for the control of urinary incontinence caused by urethral sphincter incompetence in female dogs.

Dosage & Administration:

The recommended dose of UriFlex-PT is 3 mg per kg body weight per day, divided into two or three equal oral doses. Some patients may achieve an adequate clinical response with a lower dose. Dosage may be rounded to the nearest 12.5 mg for practical dosing.

Warnings:

Not for human use. Keep this and all drugs out of reach of children. UriFlex-PT should be avoided or used cautiously in dogs with glaucoma, cardiac disease, hypertension, renal insufficiency, and diabetes mellitus.

Precautions:

UriFlex-PT should not be administered with other sympathomimetic drugs or tricyclic antidepressants, nor within two weeks of a monoamine oxidase inhibitor because of the risk of acute hypertension. UriFlex-PT may increase the risk of cardiac arrhythmias from halogenated gaseous anesthetics. Possible side-effects include restlessness, irritability, tachycardia, hypertension, and anorexia. It may take several days for the full benefit of the drug to be seen. Missed doses may negate the desired effect.

Adverse Reactions:

Adverse reactions related to administration of UriFlex-PT may include restlessness, irritability, tachycardia, hypertension, urinary retention and anorexia.

Storage:

Store between 2°-30°C (36°-86°F). Keep container tightly closed.

How Supplied:

UriFlex-PT tablets are available in 60 count and 180 count bottles.

FOR ANIMAL USE ONLY

Manufactured for BUTLER ANIMAL HEALTH SUPPLY, Dublin, OH 43017

02237

L807-0105

NAC No.: 10822342

HENRY SCHEIN® ANIMAL HEALTH
400 METRO PLACE NORTH, DUBLIN, OH, 43017-7545
Telephone:   614-761-9095
Toll-Free:   1-855-724-3461
Website:   www.henryscheinvet.com
Every effort has been made to ensure the accuracy of the UriFlex information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide